glp-1 ketosis Synergistic Effects of the Ketogenic Diet and Weight Loss Medications GLP-1 Agonists - What is

The primary outcomes were safety and tolerability, assessed by the incidence, severity, and causality of adverse events and by changes in clinical laboratory parameters and physical examinations

"Some can maintain on a lower dose, while others require ongoing therapy at their current dose." If you're like me and squeamish about the prospect of weekly injections indefinitely, take note that oral GLP-1s are now on the market: the Food and Drug Administration (FDA) approved oral Wegovy in December 2025 and Foundayo (orforglipron) in April 2026

Cost should also be clear before treatment begins

The evaluation includes fasting glucose, HbA1c, lipid panel, blood pressure, cardiac history, family history of diabetes or heart disease, and metabolic syndrome components

Initial data in the US show that the most affected categories for GLP-1 users are: Processed Foods and Snacks: declines of about 5-10% in snacks, sweets, and ultra-processed items

According to altRx: "altRx patients typically experience 1-2 lbs per week weight loss after 4 weeks, combined with a healthy diet and exercise." The company further qualifies this statement with: "Based on average weight loss reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, alongside reduced calorie intake and increased physical activity." And the brand's qualifying language continues: "Results vary based on starting weight and program adherence